The U.S. cell culture media & cell lines market, valued at USD 1.90 billion in 2024, is poised for robust expansion, projected to reach USD 4.57 billion by 2034. This growth represents a compound annual growth rate (CAGR) of 9.20% over the forecast period, fueled by accelerating biopharmaceutical R&D, stem cell innovation, and the growing application of...